DaehanPharmaceutical Logo

DaehanPharmaceutical

Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.

023910 | KO

Overview

Corporate Details

ISIN(s):
KR7023910003
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 선유로45길 3, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daehan New Pharm Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a diverse portfolio of healthcare products. Established in 1984 with an initial focus on animal medicine, the company has expanded its operations to four core business areas: human pharmaceuticals, animal pharmaceuticals, biopharmaceuticals, and health functional foods. Its product lines include a range of therapeutic agents, antibiotics, vaccines, and specialized products for both livestock and companion animals. The company places a strong emphasis on innovation, operating dedicated research institutes that focus on next-generation technologies, including cell therapy and anti-aging solutions, for both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-02 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 840.3 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 816.8 KB
2025-07-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 121.1 KB
2025-05-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 770.8 KB
2025-04-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 174.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.5 KB
2025-03-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.0 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 19.0 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 956.2 KB

Automate Your Workflow. Get a real-time feed of all DaehanPharmaceutical filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DaehanPharmaceutical

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DaehanPharmaceutical via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea
065170

Talk to a Data Expert

Have a question? We'll get back to you promptly.